247 related articles for article (PubMed ID: 20699234)
21. Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes.
Monestier M; Kotzin BL
Rheum Dis Clin North Am; 1992 May; 18(2):415-36. PubMed ID: 1626076
[TBL] [Abstract][Full Text] [Related]
22. Relationship of age and sex to autoantibody expression in MRL-+/+ and MRL-lpr/lpr mice: demonstration of an association between the expression of antibodies to histones, denatured DNA and Sm in MRL-+/+ mice.
Cohen MG; Pollard KM; Schrieber L
Clin Exp Immunol; 1988 Apr; 72(1):50-4. PubMed ID: 3260838
[TBL] [Abstract][Full Text] [Related]
23. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
24. Lupus nephritis: role of antinucleosome autoantibodies.
van der Vlag J; Berden JH
Semin Nephrol; 2011 Jul; 31(4):376-89. PubMed ID: 21839371
[TBL] [Abstract][Full Text] [Related]
25. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice.
Kramers K; Stemmer C; Monestier M; van Bruggen MC; Rijke-Schilder TP; Hylkema MN; Smeenk RJ; Muller S; Berden JH
J Autoimmun; 1996 Dec; 9(6):723-9. PubMed ID: 9115574
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA.
Losman MJ; Fasy TM; Novick KE; Monestier M
J Immunol; 1992 Mar; 148(5):1561-9. PubMed ID: 1371530
[TBL] [Abstract][Full Text] [Related]
27. SAP-less chromatin triggers systemic lupus erythematosus.
Paul E; Carroll MC
Nat Med; 1999 Jun; 5(6):607-8. PubMed ID: 10371489
[No Abstract] [Full Text] [Related]
28. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
[TBL] [Abstract][Full Text] [Related]
29. Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis.
Doria A; Gatto M
Lupus; 2012 Dec; 21(14):1492-6. PubMed ID: 23042821
[TBL] [Abstract][Full Text] [Related]
30. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
31. [Immunology in medical practice. III. Disseminated lupus erythematosus: disturbed apoptosis?].
Berden JH
Ned Tijdschr Geneeskd; 1997 Sep; 141(39):1848-54. PubMed ID: 9545742
[TBL] [Abstract][Full Text] [Related]
32. Lupus nephritis: consequence of disturbed removal of apoptotic cells?
Berden JH
Neth J Med; 2003 Aug; 61(8):233-8. PubMed ID: 14628957
[TBL] [Abstract][Full Text] [Related]
33. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
34. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
36. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
[TBL] [Abstract][Full Text] [Related]
37. Nucleosomes in the pathogenesis of systemic lupus erythematosus.
Koutouzov S; Jeronimo AL; Campos H; Amoura Z
Rheum Dis Clin North Am; 2004 Aug; 30(3):529-58, ix. PubMed ID: 15261340
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis.
Dieker J; Berden JH; Bakker M; Briand JP; Muller S; Voll R; Sjöwall C; Herrmann M; Hilbrands LB; van der Vlag J
PLoS One; 2016; 11(10):e0165373. PubMed ID: 27780265
[TBL] [Abstract][Full Text] [Related]
40. Genetic basis of murine lupus.
Santiago-Raber ML; Laporte C; Reininger L; Izui S
Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
